BACKGROUND: Although asthma and allergic rhinitis (AR) are considered to be one syndrome, many questions remain unanswered. Why do some AR patients develop asthma but others do not, and which factors play a role in the development of asthma that have so far not been clearly elucidated. OBJECTIVE: We hypothesize that children with AR who have the Clara cell secretory protein (CC16, secretoglobin 1A1) 38A/38A genotype (rs3741240) have an increased likelihood of developing asthma. METHODS: The study sample included 117 children, with AR, but no asthma diagnosed within the following 5 years, as the control group. Cases group (n=202) included age- and gender-matched children with AR first, and asthma developed 3-5 years later, as the study group. The CC16 genotype was determined by PCR and Sau96I restriction digestion of PCR products. The serum CC16 levels were measured by ELISA. Total serum IgE, allergen specific IgE, eosinophil count and pulmonary function were also measured. RESULTS: In children with rhinitis who develop asthma, the frequencies of the AA genotype were significantly higher than those who did not develop asthma [odds ratio (OR)=2.527; 95% confidence interval (CI)=1.571-4.065; P<0.01]. Serum CC16 levels in the children with rhinitis who develop asthma and carry the AA genotype were significantly lower than those who carry the non-AA genotype and those who did not develop asthma. CONCLUSIONS AND CLINICAL RELEVANCE: Results of this study suggest that CC16 38A/38A genotype plays a role in the development of early asthma in children with AR. Early identification of rhinitis children at risk may assist in designing preventative approach to asthma development.
BACKGROUND: Although asthma and allergic rhinitis (AR) are considered to be one syndrome, many questions remain unanswered. Why do some AR patients develop asthma but others do not, and which factors play a role in the development of asthma that have so far not been clearly elucidated. OBJECTIVE: We hypothesize that children with AR who have the Clara cell secretory protein (CC16, secretoglobin 1A1) 38A/38A genotype (rs3741240) have an increased likelihood of developing asthma. METHODS: The study sample included 117 children, with AR, but no asthma diagnosed within the following 5 years, as the control group. Cases group (n=202) included age- and gender-matched children with AR first, and asthma developed 3-5 years later, as the study group. The CC16 genotype was determined by PCR and Sau96I restriction digestion of PCR products. The serum CC16 levels were measured by ELISA. Total serum IgE, allergen specific IgE, eosinophil count and pulmonary function were also measured. RESULTS: In children with rhinitis who develop asthma, the frequencies of the AA genotype were significantly higher than those who did not develop asthma [odds ratio (OR)=2.527; 95% confidence interval (CI)=1.571-4.065; P<0.01]. Serum CC16 levels in the children with rhinitis who develop asthma and carry the AA genotype were significantly lower than those who carry the non-AA genotype and those who did not develop asthma. CONCLUSIONS AND CLINICAL RELEVANCE: Results of this study suggest that CC16 38A/38A genotype plays a role in the development of early asthma in children with AR. Early identification of rhinitischildren at risk may assist in designing preventative approach to asthma development.
Authors: Adam V Wisnewski; Jean Kanyo; Jennifer Asher; James A Goodrich; Grace Barnett; Lyn Patrylak; Jian Liu; Carrie A Redlich; Ala F Nassar Journal: Xenobiotica Date: 2017-06-01 Impact factor: 1.908
Authors: Christian Rosas-Salazar; Tebeb Gebretsadik; Kecia N Carroll; Sara Reiss; Nancy Wickersham; Emma K Larkin; Kristina M James; E Kathryn Miller; Larry J Anderson; Tina V Hartert Journal: Pediatr Allergy Immunol Pulmonol Date: 2015-09-01 Impact factor: 1.349
Authors: Ildikó Ungvári; Gábor Hullám; Péter Antal; Petra Sz Kiszel; András Gézsi; Éva Hadadi; Viktor Virág; Gergely Hajós; András Millinghoffer; Adrienne Nagy; András Kiss; Ágnes F Semsei; Gergely Temesi; Béla Melegh; Péter Kisfali; Márta Széll; András Bikov; Gabriella Gálffy; Lilla Tamási; András Falus; Csaba Szalai Journal: PLoS One Date: 2012-03-14 Impact factor: 3.240
Authors: Sarah J D Nauwelaerts; Koen De Cremer; Natalia Bustos Sierra; Mathieu Gand; Dirk Van Geel; Maud Delvoye; Els Vandermassen; Jordy Vercauteren; Christophe Stroobants; Alfred Bernard; Nelly D Saenen; Tim S Nawrot; Nancy H C Roosens; Sigrid C J De Keersmaecker Journal: Int J Environ Res Public Health Date: 2022-07-12 Impact factor: 4.614
Authors: Laura S Van Winkle; Shannon R Murphy; Miriam V Boetticher; Catherine A VandeVoort Journal: Environ Health Perspect Date: 2013-06-11 Impact factor: 9.031